Clinical trial
Testosterone Treatment for Hypogonadal Men
NCT00433199 · Abbott, Industry · Completed
Key facts
| NCT number | NCT00433199 |
|---|---|
| Title | Testosterone Treatment for Hypogonadal Men |
| Official title | A Multi-Center, Randomized, Double-Blind,Placebo-Controlled Efficacy and Safety Study of Testosterone Gel 1.62% for the Treatment of Hypogonadal Men |
| Lead sponsor | Abbott, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hypogonadism |
| Intervention type | Drug |
| Interventions | Testosterone (T) Gel 1.62%, Placebo |
| Enrollment | 274 |
| Start date | Feb 1, 2007 |
| Primary completion | Oct 1, 2007 |
| Completion | Apr 1, 2008 |
| First posted | Feb 9, 2007 |
| Last update posted | Jan 27, 2015 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: